Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2008-04-15
2008-04-15
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C436S173000, C600S410000, C600S420000
Reexamination Certificate
active
10761794
ABSTRACT:
An in vivo non-invasive method for detecting and/or diagnosing a pathological condition using hyperpolarized129Xe spectroscopy is disclosed. Generally stated, the method includes determining the magnitude of spectral peaks which represent particular chemical shifts and comparing the observed magnitudes to those of healthy individuals. Preferably, the method includes subtracting substantial backgrounds and accounting for secondary conditions such as the polarization of hyperpolarized gas administered. Additionally, a quantitative analysis of hyperpolarized129Xe spectra advantageously allows, a physician to establish the extent of disease progression. Advantageously, this method can be used regardless of the method of hyperpolarized129Xe administration.
REFERENCES:
patent: 5545396 (1996-08-01), Albert et al.
patent: 5617860 (1997-04-01), Chupp et al.
patent: 5642625 (1997-07-01), Cates, Jr. et al.
patent: 5809801 (1998-09-01), Cates, Jr. et al.
patent: 5936404 (1999-08-01), Ladebeck et al.
patent: 6033645 (2000-03-01), Unger et al.
patent: 6051208 (2000-04-01), Johnson et al.
patent: 6079213 (2000-06-01), Driehuys et al.
patent: 6237363 (2001-05-01), Zollinger et al.
patent: 6338836 (2002-01-01), Kuth et al.
patent: 6370415 (2002-04-01), Weiler et al.
patent: 2002/0006382 (2002-01-01), Driehuys et al.
patent: 0933062 (1999-08-01), None
patent: 2091884 (1982-08-01), None
patent: WO 97/37239 (1997-10-01), None
patent: WO99/07415 (1998-11-01), None
patent: WO 99/25243 (1999-05-01), None
patent: WO99/47940 (1999-09-01), None
patent: WO 99/52428 (1999-10-01), None
patent: WO 99/53332 (1999-10-01), None
patent: WO 00/23797 (2000-04-01), None
patent: WO00/40972 (2000-07-01), None
patent: WO01/74246 (2001-10-01), None
patent: WO02/04709 (2002-01-01), None
Albert et al., Measurement of129Xe T1 in Blood to Explore the Feasibility of Hyperpolarized129Xe.
MRI, Jour. Comp. Ass. Tomography, vol. 19, No. 6 (Nov.-Dec. 1995).
Bárány, M. et al., “High Resolution Proton Magnetic Resonance Spectroscopy of Human Brain and Liver,” Magn. Reson. Imaging, 5:393 (1987).
Bifone, et al., “NMR of laser-polarized xenon in human blood,” Proc. Natl. Acad. Sci. USA, vol. 93, pp. 12932-12936 (Nov. 1996).
Brookeman, J.R., “MRS and MRI of Hyperpolarized129Xe: Studies in Human Volunteers,” Proc. ISMRM (1998).
de Lange et al., “Lung Airspaces: MR Imaging Evaluation with Hyperpolarized Helium-3 Gas,” Radiology 210, 851-857(1999).
Diehl et al., “Nuclear Magnetic Relaxation of the129Xe and131Xe Isotopes of Xenon Gas Dissolved in Isotropic and Anistropic Liquids,” J. Magn. Reson., vol. 88, pp. 660-665 (1990).
Donnelly et al., “Cystic Fibrosis: Combined Hyperpolarized 3He-enhanced and Conventional Proton MR Imaging in the Lung—Preliminary Observations,” Radiology 212 (Sep. 1999), 885-889 (1999).
Goodson et al., “In vivo NMR and MRI Using Injection Delivery of Laser-Polarized Xenon,” 94 Proc. Natl. Acad. Sci. USA, pp. 14725-14729 (1997).
Grover, B.D., “Noble-Gas NMR Detection through Noble-Gas-Rubidium Hyperfine Contact Interaction,” Phys. Rev. Lett., vol. 40, No. 6, pp. 391-392 (1978).
Hou, et al., “Optimization of Fast Acquisition Methods for Whole-Brain Relative Cerebral Blood Volume (rCBV) Mapping with Susceptibility Contrast Agents,” J. Mag. Res. Imaging, vol. 9 pp. 233-239 (1999).
Il'yasov et al., “129Xe NMR in Study of Tissues and Plants,” Appl. Magn. Reson. vol. 17, pp. 17-84 (1999).
Jameson et al., “Nuclear Spin Relaxation by Intermolecular Magnetic Dipole Coupling in the Gas Phase. 129Xe in Oxygen,” J. Chem. Phys., vol. 89, p. 4074-4081 (1998).
Kaatz et al., “A comparison of molecular hyperpolarizabilities from gas and liquid,” J. Chem. Phys., vol. 108, No. 3, pp. 849-856 (Jan. 15, 1998).
Kaiser, et al., “Diffusion and field-gradient effects in NMR Fourier spectroscopy,” J. Chem. Phys., vol. 60, No. 8, pp. 2967-2979 (Apr. 15, 1974).
MacFall et al., “Human Lung Air Spaces: Potential for MR Imaging with Hyperpolarized He-31,” Radiology, vol. 200, No. 2, pp. 553-558 (1996).
Mansfeld et al., “The use of129Xe NMR exchange spectroscopy for probing the microstructure of porous materials,” Chem. Phys. Ltrs., vol. 213, No. 1, 2, pp. 153-157 (Oct. 1, 1993).
Martin, “The Pharmacokinetics of Hyperpolarized Xenon: Implications for Cerebral MRI,” Jour. Magn. Reson. Imag., vol. 7, No. 5, pp. 848-854 (Sep.-Oct. 1997).
McAdams et al., “Hyperpolarized 3He-Enhanced MR Imaging of Lung Transplant Recipients: Preliminary Results,” AJR 173, 955-959 (1999).
Miller et al., “Xenon NMR: Chemical shifts of a general anesthetic common solvents, proteins, and membranes”, Proc. of the Nat. Acad. of Sci. (USA), vol. 78, No. 8, pp. 4946-4949 (Aug. 1981).
Möller et. al., “Maganetic Resonance Angiography with Hyperpolarized 129Xe Dissolved in Lipid Emulsion,” 41 Mag. Res. Med. No. 5, pp. 1058-1064 (1999).
Moschos, A. et al., “Communications Nuclear Magnetic Relaxation of Xenon-129 Dissolved in Organic Solvents,” J. Mag. Reson., vol. 95, pp. 603-606 (1991).
Mugler, III et al., “MR Imaging and Spectroscopy Using Hyperpolarized 129Xe Gas: Preliminary Human Results,” Magn. Reson. In Med., vol. 37, No. 6, pp. 809-815 (1997).
Patyal, “Longitudinal Relaxation and Diffusion Measurements Using Magnetic Resonance Signals from Laser-Hyperpolarized129Xe Nuclei,” J. Magn. Reson., vol. 126, No. 1, pp. 58-65, May 1997.
Pietraβ et al., “Optically Polarized 129Xe in NMR Spectroscopy,” Advanced Materials, pp. 826-838 (1995).
Raftery, et al. , “High-Field NMR of Adsorbed Xenon Polarized by Laser Pumping,” Phys. Rev. Lett., vol. 66, No. 5, pp. 584-587 (Feb. 4, 1991).
Rosen et al., Polarized129Xe optical pumping/spin exchange and delivery system for magnetic resonance spectroscopy and imaging studies, Rev. Sci. Instrum., vol. 70, No. 2, pp. 1546-1552 (Feb. 1999).
Ruppert et al., “NMR of hyperpolarized129Xe in the canine chest: spectral dynamics during a breath-hold,” NMR Biomed., vol. 13, pp. 220-228 (2000).
Schoenborn, “Binding of Xenon to Horse Haemoglobin,” Nature, vol. 208, pp. 760-762 (Nov. 20, 1965).
Swanson et al., “Brain MRI with Laser-Polarized129Xe,” Mag. Res. Med., vol. 38, pp. 695-698 (1997).
Tilton, Jr., et al, “Nuclear Magnetic Resonance Studies of Xenon-129 with Myoglobin and Hemoglobin,” Biochemistry, vol. 21, No. 26, pp. 6850-6857 (1982).
Tseng et al., “NMR of Laser-Polarized129Xe in Blood Foam,” J. Mag. Res., vol. 126, pp. 79-86 (1997).
Wolber et al., “Spin-lattice relaxation of laser-polarized xenon in human blood,” 96 Proc. Natl. Acad. Sci. USA, pp. 3664-3669 (Mar. 1999).
Wolber et al. “In vivo hyperpolarized129Xe spectroscopy in tumors,” Proc. Int'l. Mag. Reson. Med. 8, 1440 (2000).
Wolber et al. “In vivo hyperpolarized129Xe spectroscopy in tumors” Mag. Reson. Med. 46, pp. 586-591 (2001).
Albert, et.al., “Susceptibility Changes Following Bolus Injections”, Appendix B reprint from Magnetic Resonance in Medicine 29 700-708 (1993).
Belliveau et.al., Functional Cerebral Imagining by susceptibility-Contrast NMR, dated Dec. 7, 1989; Magnetic Resonance in Medicine 14, 538-546 (1990).
Chupp, et.al., “Chemical Shift Imaging of Laser-Polarized129XE Magnetization in Rats In Vivo”, European Radiology 9:B45 (1999).
Driehuys, et.al., “Surface Relaxation mechanisms of Laser-Polarized129XE”, Physical Review Letters vol. 74, No. 24, p. 4943-4946, dated Jun. 12, 1995.
Luhmer, et.al., “Study of Xenon Binding Cryptophane-A Using Laser-Induced NMR Polarization Enhancement”, J. Am. Chem. Soc. Mar. 30, 1999, 121, 3502-3512.
Mazitov, et.al., “NMR Spectroscopy of 129Xe Dissolved in Tissues of Animals and Plants in vitro: Effect of Tissue wit
Chisholm Robert F.
Hartley Michael G.
Medi--Physics, Inc.
Schlientz Leah
LandOfFree
Diagnostic procedures using 129 Xe spectroscopy... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic procedures using 129 Xe spectroscopy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic procedures using 129 Xe spectroscopy... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3934548